The Earlier the Better: Probing Malignancies in Newborns
(L-R) Prof.Wolfgang Holzgreve, Prof. Marek Glazerman, Prof. Israel Meisner
Building on their established international partnership, GE Healthcare and Rabin Medical Center are developing innovative products and working on creative medical solutions to facilitate the early diagnosis of medical problems in pregnant women and their fetuses. An international data registry on fetal tumors is already in progress, which will assist in treating malignant conditions in both fetuses and newborns. Prof. Israel Meisner, head of RMC's Obstetric Ultrasound Unit, said tumors such as Neuroblastoma can be fully cured if discovered early in a fetus, and he believes this registry is important.
The data registry project was inaugurated during a conference at Rabin Medical Center on Women's Healthcare organized by GE Healthcare Israel, headed by Tony Bachar, and by the Rabin Medical Center's Women's Hospital, headed by Prof. Marek Glazerman. Among the honored guests present was Prof. Wolfgang Holzgreve, head of obstetrics and gynecology at the renowned University of Basel in Switzerland.
Related Articles
AFRMC Thanks Its Sponsors: 2016 Cheryl Diamond Nyc 5k Schlep Run / Walk for Breast & Ovarian Cancer Research & Treatment
The Sixth Annual Cheryl Diamond NYC 5k Schlep Run / Walk in Battery Park on June 5, 2016 highlighted the BRCA Gene Multidisciplinary Clinic, serving women at high risk of breast and ovarian cancer.
7 Facts About Menopause
By Prof. Barry Kaplan, Deputy Chairman, Women's Hospital, Rabin Medical Center, President of the Israeli Society for Menopause
Lifesaving Heroics
Professor Israel Meizner, head of
the Ultrasound Unit at Rabin
Medical Center's Hospital for
Women, has performed thousands
of ultrasounds and invasive procedures
on pregnant women throughout
his long career, but nothing like
the extraordinary ultrasound of
Limor Agamy.